Therefore, an electrochemical cytosensing method to evaluate the efficacy of dasatinib and TRAIL, by identifying the presence of caspase-3 in apoptotic CML cells, was studied [103]. This evidence concerns the gene TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive.